首页> 外国专利> Bivalent Antibody isolated Bivalent or fragment thereof,Acting on LRP6 Boosting a Wnt Signal to Group one or more receptor LRP6 in presence of a Binding Protein LRP6; Nucleic Acid encodes it; vector comprising Said acid NUCLinoleic; Pharmaceutical composition comprising a multivalent Antibody anti LRP6; and their use to treat cancer.

Bivalent Antibody isolated Bivalent or fragment thereof,Acting on LRP6 Boosting a Wnt Signal to Group one or more receptor LRP6 in presence of a Binding Protein LRP6; Nucleic Acid encodes it; vector comprising Said acid NUCLinoleic; Pharmaceutical composition comprising a multivalent Antibody anti LRP6; and their use to treat cancer.

机译:二价抗体分离的二价或其片段,在结合蛋白LRP6存在下,作用于LRP6,增强Wnt信号以将一个或多个受体LRP6分组。核酸编码它;包含所述酸核糖核酸的载体;药物组合物,其包含多价抗体抗LRP6;及其用于治疗癌症。

摘要

Bivalent Antibody isolated Bivalent or fragment thereof,Acting on LRP6 Boosting a Wnt Signal to Group one or more receptor LRP6 in presence of a Binding Protein LRP6; Nucleic Acid encoding the Vector comprising Said NUC acid;Linoleic; Pharmaceutical composition comprising a multivalent Antibody anti LRP6; and their use to treat cancer.
机译:二价抗体分离的二价或其片段,在结合蛋白LRP6存在下,作用于LRP6,增强Wnt信号以将一个或多个受体LRP6分组。编码包含所述NUC酸的载体的核酸;亚油酸;药物组合物,其包含多价抗体抗LRP6;及其用于治疗癌症。

著录项

  • 公开/公告号CL2012003094A1

    专利类型

  • 公开/公告日2013-03-22

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG.;

    申请/专利号CL20120003094

  • 申请日2012-11-06

  • 分类号A61K39/395;A61P35/00;C07K16/28;C07K16/46;C12N15/13;C12N15/63;

  • 国家 CL

  • 入库时间 2022-08-21 16:42:10

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号